跳至主要内容
临床试验/NL-OMON23171
NL-OMON23171暂停不适用

TropicALL study: <br>Thromboprophylaxis in Children treated forAcute Lymphoblastic Leukemia withLow-molecular-weight heparin:a randomized controlled trial

Dutch Childhood Oncology Group (DCOG)Stichting Kinderoncologie Nederland (SKION)0 个研究点目标入组 354 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
354

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All patients between 1 and 19 years of age with primary ALL, who are eligible for and treated within the DCOG ALL-11 or 12 study protocol.

排除标准

  • a.Patients who are already being treated with anticoagulation upon screening (for other indications)
  • b.Patients with a heparin allergy (or for one of its components), a recent history (within 6 months) of heparin-induced thrombocytopenia (HIT) or any other contraindication listed in the local labeling of LMWH

研究者

发起方
Dutch Childhood Oncology Group (DCOG)Stichting Kinderoncologie Nederland (SKION)

相似试验